Wegovy vs Mounjaro for Weight Loss in India: The Complete 2026 Guide
Home/Categories/Wegovy vs Mounjaro for Weight Loss in India: The Complete 2026 Guide
Wegovy vs Mounjaro in India (2026) – Cost, Safety & Results
Introduction: India at the Heart of a Global Weight-Loss Revolution
A few years ago, if you asked about medical weight-loss injections in India, the answer was simple: “Not available here yet.” Fast forward to 2026, and India is now one of the most competitive and affordable places in the world to start these therapies.
“Doctor, should I start Wegovy or Mounjaro? Which one really works better?”
It’s a question worth asking. With obesity affecting 650 million people globally (WHO, 2024) and 135 million Indians(ICMR 2023 estimates), the demand for safe, effective solutions has never been higher.
Both Wegovy(semaglutide) and Mounjaro (tirzepatide) have transformed obesity care — but choosing the right one depends on your body, your goals, and expert guidance.
As Dr. Reema Arora explains:
“These drugs are tools, not magic bullets. The best results come when they’re prescribed under supervision, combined with lifestyle changes, and monitored for long-term safety.”
Table of Contents
Eligibility and Dosing: Who Can Start These Injections?
BMI Cut-offs:
BMI ≥ 30 (obesity)
BMI ≥ 27 (with weight-related conditions such as diabetes, hypertension, or PCOS)
Dosing Schedules:
Wegovy (Semaglutide): Starts at 0.25 mg weekly, titrated up every 4 weeks to 2.4 mg maintenance.
Mounjaro (Tirzepatide): Starts at 2.5 mg weekly, titrated gradually to 15 mg maintenance.
This slow titration is why most patients tolerate them better under doctor supervision, with reduced nausea and GI side effects.
Baseline Medical Tests (Recommended): Before starting, patients undergo tests such as blood sugar (HbA1c), kidney and liver function, lipid profile, and thyroid screening. This ensures safety and personalization of dosage.
The Science Behind Wegovy and Mounjaro
Wegovy (Semaglutide)
Key Trial: SURMOUNT-1 (NEJM, 2022) → Average 20.9% body weight loss over 72 weeks; nearly 25 kg on average.
Bonus:DCGI-approved in India, with dramatic improvements in blood sugar → especially powerful for type 2 diabetics.
Wegovy vs Mounjaro Effectiveness
Wegovy: ~15% weight loss (~15 kg for a 100 kg patient).
Mounjaro: ~20–22% weight loss (~20–22 kg for the same patient).
Translation: Mounjaro often delivers 5–7% more weight loss, but Wegovy has more long-term cardiovascular safety data.
Side Effects and Safety
Common (temporary): nausea, constipation, bloating, diarrhea. Less common (serious): pancreatitis, gallbladder issues, thyroid C-cell tumors. Contraindications: pregnancy, history of medullary thyroid carcinoma or MEN2.
With gradual dose titration + regular checkups + baseline monitoring, most patients tolerate treatment well.
Wegovy vs Mounjaro Cost in India (2026)
Here’s the game-changer:
United States:
Wegovy: ~$1,300/month (≈₹1.1 lakh)
Mounjaro: ~$1,000–1,200/month (≈₹85,000–1 lakh)
Europe:
€800–1,000/month (≈₹70,000–85,000)
India:
Wegovy: ₹15,000–₹25,000/month
Mounjaro: ₹15,000–₹25,000/month
That’s nearly 5–6x more affordable than the U.S.
At The Face Clinic, Hauz Khas, we tell patients: this isn’t a “celebrity-only” drug anymore. It costs about the same as a premium gym membership or a year of personal training — but with proven medical results.
Wegovy vs Mounjaro: Pros & Cons
Feature
Wegovy
Mounjaro
Mechanism
GLP-1 only
GLP-1 + GIP
Avg. Weight Loss
~15%
~20–22%
Cardiovascular Data
Strong, proven
Promising, ongoing
Side Effects
GI issues
Slightly stronger GI effects
India Cost (2026)
₹15–25K/month
₹15–25K/month
Beyond Weight Loss: Added Benefits
Wegovy: Reduces risk of heart attack & stroke.
Mounjaro: Improves blood sugar, insulin resistance, and reduces liver fat.
Both: Boost confidence, energy, and quality of life.
Myths vs Facts
Myth: “These are shortcuts.” Fact: They work best with diet, exercise, and lifestyle support.
Myth: “Results are permanent.” Fact: Some regain happens if stopped without maintenance.
Myth: “Too expensive in India.” Fact: At ₹15–25K/month, India offers one of the lowest global costs.
Why India is the Most Affordable Market
For global readers: starting Wegovy or Mounjaro in India isn’t just safe — it’s cost-effective. Many medical tourists combine treatments with wellness travel, saving 70–80% compared to U.S. prices.
At The Face Clinic, South Delhi, Dr. Reema blends these advanced medications with nutrition, IV drips, and non-surgical body contouring — ensuring results are safe, impressive, and sustainable.
Ready to explore Wegovy or Mounjaro safely in Delhi? Book your consultation today and take the first step towards a healthier, more confident you.
Because in 2026, it’s not about choosing Wegovy or Mounjaro. It’s about choosing the right doctor, the right program, and the right future.